Delapril versus manidipine in hypertensive therapy to halt the type-2- diabetes-mellitus-associated nephropathy

Diabetes Research and Clinical Practice

Volumn 47, Issue 2, 2000, Pages 97-104

  Shiba, Teruo ^a   Inoue, Masahiro ^b   Tada, Hisaya ^c   Hayashi, Yoichi ^d   Okuda, Yukichi ^e   Fujita, Rie ^e   Makino, Fuminori ^f   Takahasi, Chieko ^g   Kageyama, Shigeru ^h   Kitamura, Shinichi ⁱ   Iwamoto, Yasuhiko ^g  

^a MITSUI MEMORIAL HOSPITAL   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ Saiseikai Mukojima Hospital   (Japan)

Author keywords

Delapril; Diabetic nephropathy; Hypertension; Manidipine; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; CALCIUM ANTAGONIST; CREATININE; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MANIDIPINE;

ADULT; AGED; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; KIDNEY TUBULE FUNCTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIHYDROPYRIDINES; FEMALE; HUMANS; HYPERTENSION; INDANS; MALE; MIDDLE AGED;

EID: 0033987102     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00114-X     Document Type: Article

References (22)

1. Parving H.-H. Hypertension and diabetes. Marshall S.M., Home P.D., Alberti K.G.M.M., Krall L.P. The Diabetes Annual 7. 1993;127-145 Elsevier, Amsterdam.
2. Epstein M., Sowers J.R. Diabetes mellitus and hypertension. Hypertension. 19:1992;403-418.
3. Ritz E. Hypertension in diabetic nephropathy: prevention and treatment. Am. Heart. J. 125:1993;1514-1519.
4. Mogensen C.E. Long-term anti-hypertensive treatment inhibiting progression of diabetic nephropathy. Br. Med. J. 285:1982;685-693.
5. Parving H.-H., Andersen A.R., Smidt U.M., Hommel E., Mathiesen E.R., Svendsen P.A. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br. Med. J. 294:1987;1443-1447.
6. Lewis E.J., Hunsicker L.G., Bain R.P., Rhode R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 329:1993;1456-1462.
7. Mathiesen E.R., Hommel E., Giese J., Parving H.-H. E increased efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. Br. Med. J. 303:1991;81-87.
8. Muratani H., Fukiyama K., Kamiyama T. et al. Current status of antihypertensive therapy for elderly patients in Japan. Hypertens. Res. 19:1996;281-290.
9. Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet. 349:1997;1787-1792.
10. Passa P., Leblanc H., Marre M. Effects of enalapril in insulin dependent diabetic patients with mild to moderate uncomplicated hypertension. Diabetes Care. 10:1987;200-204.
11. Ahmad J., Siddiqui M.A., Ahmad H. Effective postponement of diabetic nephropathy with enalapril in normotensive Type II diabetic patients with microalbuminuria. Diabetes Care. 20:1997;1756-1781.
12. Ravid M., Savin H., Jutrin I., Bental T., Katz B., Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann. Intern. Med. 118:1993;577-581.
13. Chan J.C.N., Cockram C.S., Nichlls M.G., Cheung C.K., Swaminathan R. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. Br. Med. J. 305:1992;981-985.
14. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbumiuria. Br. Med. J. 302:1991;210-216.
15. Fogari R., Zoppi A., Malamani G.D., Lusardi P., Destro M., Corradi L. Effects of amlodipine vs. enalapril on microalbuminuria in hypertensive patients with type II diabetes. Clin. Drug. Invest. 13:1997;42-49.
16. Bakris G.L., Copley J.B., Vicknair N., Saddler R., Leurgans S. Calcium channel blockers versus other antihypertensive therapies on progression of type II diabetes mellitus associated nephropathy. Kidney Int. 50:1996;1641-1650.
17. Holdaas A., Hartmann A., Lien M.G. et al. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J. Intern. Med. 229:1991;163-170.
18. Mimran A., Insua A., Ribstein J., Bringer J., Monnier L. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care. 11:1988;850-853.
19. Kasiske B.L., Kalil R.S.N., Ma J.Z., Liao M. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann. Intern. Med. 118:1993;129-138.
20. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 317:1998;703-713.
21. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ. 317:1998;713-720.
22. Murakami K., Kimura G., Imanishi M. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension. Blood Pressure. 1:1992;s114-s118.